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Abstract
Background: High mobility group A (HMGA) proteins regulate gene transcription through architectural modulation
of chromatin and the formation of multi-protein complexes on promoter/enhancer regions. Differential expression
of HMGA variants has been found to be important for distinct differentiation processes and deregulated expression
was linked to several disorders. Here we used mouse C2C12 myoblasts and C2C12 cells stably over-expressing
HMGA1a-eGFP to study the impact of deregulated HMGA1 expression levels on cellular differentiation.
Results: We found that induction of the myogenic or osteogenic program of C2C12 cells caused an immediate
down-regulation of HMGA1. In contrast to wild type C2C12 cells, an engineered cell line with stable over-
expression of HMGA1a-eGFP failed to differentiate into myotubes. Immunolocalization studies demonstrated that
sustained HMGA1a-eGFP expression prevented myotube formation and chromatin reorganization that normally
accompanies differentiation. Western Blot analyses showed that elevated HMGA1a-eGFP levels affected chromatin
composition through either down-regulation of histone H1 or premature expression of MeCP2. RT-PCR analyses
further revealed that sustained HMGA1a expression also affected myogenic gene expression and caused either
down-regulation of genes such as MyoD, myogenin, Igf1, Igf2, Igfbp1-3 or up-regulation of the transcriptional
repressor Msx1. Interestingly, siRNA experiments demonstrated that knock-down of HMGA1a was required and
sufficient to reactivate the myogenic program in induced HMGA1a over-expressing cells.
Conclusions: Our data demonstrate that HMGA1 down-regulation after induction is required to initiate the
myogenic program in C2C12 cells. Sustained HMGA1a expression after induction prevents expression of key
myogenic factors. This may be due to specific gene regulation and/or global effects on chromatin. Our data further
corroborate that altered HMGA1 levels influence the expression of other chromatin proteins. Thus, HMGA1 is able
to establish a specific chromatin composition. This work contributes to the understanding of how differential
HMGA1 expression is involved in chromatin organization during cellular differentiation processes and it may help
to comprehend effects of HMGA1 over-expression occurring in malign or benign tumours.
Background
Chromatin provides a platform to regulate gene expres-
sion during several biological processes such as cellular
differentiation events. Epigenetic programs involve DNA
methylation patterns and/or stable modifications of his-
tone tails [1,2]. Most if not all chromatin proteins asso-
ciating with nucleosomal chromatin bind only
transiently and are part of dynamic networks that
regulate chromatin organization and function. High
mobility group (HMG) proteins are members of these
dynamic networks [3]. All members of the three HMG-
families are considered as architectural chromatin pro-
teins. Nevertheless, each family or even each family
member play distinct roles in chromatin function [3,4].
The mammalian HMGA family consists of four mem-
bers. Alternative splicing of the HMGA1 transcript gives
rise to three variants, HMGA1a, 1b, and 1c while
HMGA2 is encoded by a separate gene. Proteins of the
HMGA family are characterized by conserved DNA-
binding domains, the AT-hooks, and an acidic
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DNA which is considered to be the major reason for
their concentration in heterochromatin [3,5,6]. HMGA
proteins affect the expression of many genes through
architectural remodeling of the chromatin structure and
by stabilizing nucleoprotein complexes called enhanceo-
somes built on promoter/enhancer regions [7,8]. In
addition, HMGA proteins are part of further chromatin
complexes, as has been shown for the pre-replication
complex [9] and are able to influence the structure and
function of large chromatin domains [8,10].
During development HMGA proteins are highly
expressed in early embryos and undifferentiated cells
but are absent in differentiated cells [4]. Thus, a regu-
lated HMGA expression is important for proper cell
function and differentiation. High expression levels are
found in many tumors and correlate with tumor malig-
nancy [11], are linked to deregulated oncogenes and
contribute to genomic instability by inhibition of proper
nucleotide excision repair [12]. Several reports indicated
that HMGA proteins influence expression of genes in a
cell type specific manner [4].
Loss of Hmga1 or Hmga2 gene function affects speci-
fic differentiation processes [4]. Hmga1 knockout mice
develop type 2 diabetes due to a reduced expression of
the insulin receptor [13], cardiac hypertrophy and
myelo-lymphoproliferative disorders [14]. HMGA2 was
shown to be crucial for cardiogenesis through regulating
the gene Nkx2.5, a cardiogenic key transcription factor
[15]. A pygmy phenotype of mice is caused by a dis-
rupted Hmga2 gene and characterized by drastic reduc-
tion of fat tissue and a deficient spermatogenesis [16,17].
Here, we demonstrate that after induction of myogen-
esis in C2C12 cells down-regulation of HMGA1 proteins
is an early and required step allowing the progression of
the myogenic program. Sustained HMGA1a expression
prevented myogenic differentiation and altered the chro-
matin composition through interfering with the expres-
sion of myogenic genes and other architectural
chromatin proteins.
Results
Down-regulation of HMGA1 proteins during cellular
differentiation
Murine C2C12 cells are committed cells that initiate
muscle differentiation upon growth factor withdrawal or
initiate osteogenesis upon addition of the growth factor
BMP2. After induction of the myogenic program major
morphological changes in C2C12 cells occurred on day
1-3 (cellular elongation) and on days 6-9 (cell fusion
and myotube formation). Analyses of Hmga1 expression
by RT-PCR and Western blots revealed an immediate
down-regulation of Hmga1 expression after induction of
myogenic differentiation reaching low or undetectable
levels on day 3 and subsequent time points during dif-
ferentiation, respectively (Fig. 1A). Similarly, induction
of osteogenesis by BMP2 also caused down-regulation
of Hmga1 mRNA with a delayed onset compared to the
down-regulation during myogenesis. Interestingly,
HMGA1 protein levels remained well detectable even
after 4 days of osteogenic differentiation (Fig. 1B). The
persistence of HMGA1 protein compared to the absence
of detectable mRNA might result from different protein
stabilities dependent on the cellular context during the
two differentiation pathways. These data support that
Hmga1 expression is only prominent in undifferentiated
cells but down-regulated after the initiation of differen-
tiation upon external stimuli.
Characterization of C2C12 cells stably expressing
HMGA1a-eGFP
To assess whether Hmga1 down-regulation is required
for cell differentiation we generated C2C12 cells stably
over-expressing HMGA1a-eGFP (C2A1a cells). As pre-
viously shown, HMGA1a-eGFP fusion proteins behave
like endogenous proteins [6]. HMGA1a-eGFP expression
was constant throughout the entire time the C2A1a cells
were cultured under myogenic induction conditions
(Fig. 2A). Western blots revealed that the over-expres-
sion of exogenous HMGA1a-eGFP in C2A1a cells
resulted in a prolonged expression of endogenous
HMGA1. The latter was still detectable six days after
culturing C2A1a cells in differentiation medium while
HMGA1 was undetectable in C2C12 wild type cells
Figure 1 Differential expression of HMGA1 proteins during
C2C12 cell differentiation. (A) Down-regulation of HMGA1 during
myogenic differentiation of C2C12 cells as analyzed by PCR and
Western blotting (WB). For Western blots proteins of 1.5 × 10
5
nuclei were separated on a 15% SDS-polyacrylamide gel. For RT-PCR
1 μg of total RNA was used to produce cDNAs for the PCR reaction.
For PCR identical amounts of cDNA were used. Time points of
analyses are indicated in days. The arrowhead marks the time point
of induction. Day 0 denotes non-induced myoblasts. Gapdh
expression served as a control for the reverse transcription in RT-
PCR experiments. As a control for loading and Western blotting
Ponceau staining (P) of core histones is shown. (B) Down-regulation
of HMGA1 expression during osteogenesis. Osteogenesis in C2C12
cells was induced with 0.5 μg/ml BMP2 (arrowhead) and HMGA1
expression was analyzed at day 0 and on days 1, 3 and 4 after by
RT-PCR (RT) and Western blot (WB) as described in (A).
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exogenous HMGA1-eGFP were detected in parallel by
an HMGA1-specific antibody to compare relative
expression levels (Fig. 2A). Semi-quantitative densito-
metric evaluation of Western blots using ImageJ indi-
cated a ~2.6-fold over-expression of HMGA1 proteins
as compared to endogenous HMGA1 in wild type
myoblasts.
In living C2A1a cells, HMGA1a-eGFP preferentially
localized throughout the cell cycle in heterochromatin
foci which represent pericentromeric regions fused into
larger entities called chromocenters (Fig. 2B). In inter-
phase cells it colocalized with markers for heterochro-
matin such as HP1a, histone H3 trimethylated at K9 or
histone H4 trimethylated at K20 (Fig. 2C, D). In agree-
ment with previous data that linked increased HMGA
levels to enhanced cell proliferation, we counted a 2.6-
fold increase in the C2A1a cell number 24 hours after
seeding the same amount of C2C12 and C2A1a cells.
FACS analyses revealed a similar cell cycle stage distri-
bution of the transformed and parental cells (Fig. 2E).
Stable expression of HMGA1a prevents myogenic
differentiation of C2C12 cells
To compare myogenesis in C2C12 and C2A1a cells we
used immunolocalization experiments as well as RT-
PCR. Immunofluorescence indicated that C2A1a cells,
but not C2C12 cells, failed to fuse and to form myosin
Figure 2 Characterization of the HMGA1a-eGFP over-expressing cell line C2A1a. (A) Sustained expression of HMGA1a-eGFP in C2A1a cells
throughout myogenic induction analyzed by RT-PCR and Western blotting (WB) as indicated. Both, fusion protein (~45 kDa) and endogenous
protein (~17 kDa) were detected using an HMGA1-specific antibody. Note the sustained expression throughout myogenic induction. Loading
controls are as mentioned in Fig. 1. (B) Localization of HMGA1a-eGFP in living C2A1a cells. Note the concentrated localization in heterochromatin
foci (chromocenters) during interphase (a) and on pericentromeric regions during mitosis (b). Scale bars represent 10 μm. (C) Immunolocalization
on fixed C2A1a cells using HP1a-specific antibodies. Note the colocalization of HMGA1a-eGFP (a’) and HP1a (a’’) in the chromocenters of C2A1a
cells. DNA was stained with Hoechst (a). An overlay of a-a’’ is shown in a’’’. The bar represents 10 μm. (D) HMGA1a-eGFP (green) colocalizes with
the H3K9me3 and H4K20me3 specific immunolocalizations (red) in C2A1a cells. DNA was stained with Hoechst. The bar represents 10 μm. (E)
Cell cycle phases are unaffected in the C2A1a cell line. DNA from C2C12 and C2A1a was stained with propidium iodide and 20,000 cells from
each cell line were analyzed by FACS. Cell numbers (counts) are plotted against the relative DNA content of the cells. Phase distribution was
analyzed with modfit Lt3.1. 56.14% of C2C12 cells were in G1 phase, 29.54% in S phase, and 14.33% in G2 phase. In C2A1a cells 60.95% of the
cells were in G1 phase, 24.43% in S phase, and 14.63% in G2 phase.
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expression of a-actin and myosin light chain mRNA as
a marker for myogenic differentiation. In C2C12 cells,
transcripts of both markers were detectable by RT-PCR
shortly after induction of differentiation (Fig. 3B, left).
In contrast, they were absent in C2A1a cells grown for
at least 9 days in differentiation medium (Fig. 3B, right).
On the contrary, as monitored by expression of alkaline
phosphatase and osteocalcin, early osteogenesis was not
affected (Fig. 3C, D). Together these data demonstrate
that sustained expression of HMGA1a does not interfere
with early osteogenic events but specifically impairs
myogenesis in C2C12 cells.
Sustained HMGA1a expression prevents chromocenter
remodeling
Reorganization of chromatin accompanies cellular differ-
entiation. In C2C12 cells, differentiation associated chro-
matin reorganization is visual as clustering of
chromocenters during terminal differentiation leading to a
reduced chromocenter number in differentiated cells [18].
To examine whether variations in HMGA1 levels partici-
pate in chromocenter remodeling we compared their
numbers in C2C12 cells, C2A1a cells (increased HMGA1
level) and C2A1a cells after HMGA1 knock-down through
siRNA (reduced HMGA1 level). Successful knock-down of
endogenous HMGA1 and HMGA1a-eGFP was verified by
Figure 3 HMGA1a over-expression prevents myogenic differentiation. (A) Immunofluorescence localization of myosin (red) in C2C12 (a-e)
and in C2A1a cells (f-k) before (myoblast) and after induction (days 1 to 9). All bars represent 20 μm. Myotube formation was only observed in
wild type C2C12 cells. In pictures a-e DNA staining by Hoechst is shown in blue, respectively. HMGA1a-eGFP is shown in green. (B) RT-PCR
analysis to compare the expression of the myosin light chain (myosin lc) and a-actin in C2C12 cells (left) and in C2A1a cells (right) as described
in Fig. 1. Expression of Hmga1, Gapdh and desmin are shown as controls. (C) RT-PCR to analyze expression profiles of marker genes for
osteogenesis. Genes analyzed were alkaline phosphatase (AP) and osteocalcin. Gapdh expression is shown as control. HMGA1a over-expression
did not affect AP and osteocalcin transcription. (D) Alkaline phosphatase activity as marker for osteogenesis of C2C12 and C2A1a cells on day 2
of differentiation (bright field images). AP activity was visualized using NBT/BCIP staining. Shown are overlays of bright field images and
fluorescence images with corresponding DNA staining. Scale bar is 50 μm.
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analyses (Fig. 4B). Number and distribution of chromocen-
ters were found to be almost identical in non-induced
C2C12- and C2A1a-myoblasts (Fig. 4C, a). Consistent
w i t hB r e r oe ta l . ,[ 1 8 ] ,r e d uced chromocenter numbers
indicated chromocenter clustering in terminally differen-
tiated C2C12 cells (Fig. 4C, b grey bars). In contrast, even
after growing C2A1a cells for 6 days in differentiation
medium, the number of chromocenters remained
comparable to the number of chromocenters in non-
induced cells or even shifted to an increased percentage of
cells with increased chromocenter number (Fig. 4C, b).
Thus, HMGA1 over-expression prevented chromocenter
clustering which occurs normally through terminal differ-
entiation and stabilized a chromocenter distribution com-
parable to non-induced myoblasts.
We further asked, what happens to the chromocenter
organization after HMGA1a knock-down. Therefore, we
Figure 4 HMGA1a over-expression interferes with chromatin organization during myogenesis. (A) Depletion of HMGA1a-eGFP after
HMGA1a-siRNA treatment is visual through the loss of eGFP fluorescence in C2A1a cells (b). Mock transfected C2A1a cells are shown in a. The
corresponding Hoechst stained images are shown in a’ and b’. The bar represents 20 μm. (B) Western blot analysis showed considerable
depletion of endogenous and eGFP-tagged HMGA1a proteins, respectively, 12-24 hours after siRNA treatment of C2C12 and C2A1a cells.
Ponceau staining (P) of the core histones is presented as loading control. Protein molecular mass is indicated in kDa. (C) Heterochromatin foci
(chromocenters) in C2C12 and C2A1a cells were quantified (n = cell number) and plotted as indicated. (a) In myoblasts (day 0) the number of
chromocenters is identical in both cell lines. (b) During terminal muscle differentiation of the C2C12 cells, the number of heterochromatin foci
decreases due to chromocenter clustering (grey columns) whereas the chromocenter number in C2A1a cells remains comparable to the number
in myoblasts (green columns). (D) C2A1a control cells (a) and C2A1a cells 12-24 hours after siRNA treatment (b). HMGA1 depletion, indicated by
absence of HMGA1a-eGFP, results in a higher number and a reduced size of chromocenters (arrowheads) (b’). The bar represents 10 μm. (E)
Depletion of HMGA1 by siRNA in C2A1a myoblasts increased the chromocenter number (red columns) compared to C2A1a control cells (green
columns). A similar chromocenter dissociation was detected in C2C12 wild type cells on differentiation day 3 (grey columns) prior to fusion
during terminal differentiation.
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blasts that lost their eGFP fluorescence as a marker for
HMGA1 knock-down after Hoechst staining (Fig. 4D).
Of note, the fraction of cell nuclei with more than 30
chromocenters significantly increased from 2.8% to 42%
in cells without eGFP fluorescence (p < 0.001). This sug-
gests that reduced HMGA1 protein level in non-induced
C2C12 cells lead to a reduced chromocenter stability. It
s h o u l db en o t e dt h a tc h r o m ocenter dissociation was
observed transiently between 12-24 hours after HMGA1
knock-down through siRNA treatment (Fig. 4E). Com-
parable chromocenter dissociation was observed in
C2C12 cells around day 3 of differentiation when endo-
genous HMGA1 is down-regulated (Fig 4E, grey bars)
indicating that transient chromocenter dissociation
naturally and transiently occurs prior to chromocenter
clustering. Together this suggests that HMGA1a over-
expression stabilizes chromocenters and prevents their
remodeling prior to clustering during terminal
differentiation.
HMGA1 over-expression alters global chromatin
composition
HMG proteins have been shown to globally affect chro-
matin organization and function as players in dynamic
networks through regulating the access of other factors
and modulators to chromatin [3]. Little is known about
how HMG proteins affect chromatin composition
through affecting expression of other architectural chro-
matin proteins. We therefore examined by Western
blotting how over-expression of HMGA1a influences
the expression of HMGB1, HMGN1 and histone H1
during cellular differentiation (Fig. 5A). The expression
levels of HMGB1 and HMGN1 were different in C2C12
and C2A1a cells, displaying a slight down-regulation
especially at day 1 after induction of C2A1a cells. Nota-
bly, histone H1 levels were constantly decreased in
C2A1a cells before and throughout induction of myo-
genesis. In contrast, histone H1 levels remained unaf-
fected after HMGA1a knock-down in uninduced C2C12
cells (Fig. 5B). This suggests that the effect on histone
Figure 5 HMGA1a over-expression alters the chromatin composition. (A) Western blot analyses comparing the expression of HMGB1, HMGN1,
and histone H1 in C2C12 cells and C2A1a cells in myoblasts (day 0) and on days 1 and 3 of differentiation. The antibody used [43] recognizes all
histone H1 variants. Proteins of 1.5 × 10
5 cells were analyzed in 15% SDS-PAGE. Lamin A/C expression and Ponceau S staining are shown as loading
controls. (B) Histone H1 levels are unaffected in C2C12 cells after HMGA1 knock-down. Western blot was as described in Fig. 5A. Antibodies used
are indicated. Histone H1 antibody used was directed against all H1-sub-variants (Abcam). Cells were untreated (-), siRNA treated (+) or transfected
using siRNA control oligos (Ctrl). Ponceau S staining is shown as loading control. (C) Western blot analysis comparing MeCP2 expression in C2C12
and C2A1a cells. Note the premature MeCP2 expression in C2A1a cells. (D) Immunofluorescence localization of MeCP2 in C2C12 and C2A1a cells.
MeCP2 is hardly detectable in C2C12 myoblasts (a’) but accumulates in chromocenters of C2A1a cells (b). MeCP2 is concentrated in fused
chromocenters in C2C12 cells (c’) and is accumulated in chromocenters of C2A1a cells on day 6 after induction (d’). Note the absence of
chromocenter clustering. Corresponding DNA staining is shown in a, b, c and d, respectively. Scale bars represent 10 μm.
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expressed in C2A1a cells and that the down-regulation
of histone H1 may be an indirect effect.
During differentiation of C2C12 cells the heterochroma-
tin associated methyl-CpG-binding protein MeCP2 is
highly expressed only during terminal differentiation and
involved in chromocenter clustering [18]. In contrast to
HMGA1, over-expression of MeCP2 is sufficient to cause
chromocenter clustering even in the absence of differen-
tiation [18]. Therefore, we examined MeCP2 expression in
more detail. Consistent with Brero et al. [18] we found
that MeCP2 expression in C2C12 cells started at day 6 of
differentiation (Fig. 5C, left) and only a minor fraction of
MeCP2 was localized in chromocenters of myoblasts (Fig.
5D, a’). On day 6 of differentiation MeCP2 was concen-
trated in fused chromocenters in C2C12 cells (Fig.5D, c’).
In contrast, we detected a premature expression of
MeCP2 in C2A1a cells (Fig. 5C, right) and MeCP2 was
already accumulated in chromocenters of C2A1a myo-
blasts (Fig. 5D, b’). Nevertheless, as mentioned earlier,
chromocenter clustering was prevented in C2A1a cells
(Fig. 5D, d’). Thus, HMGA1a over-expression elevates
the expression of MeCP2 but also counteracts its cap-
ability to cause heterochromatin fusion.
Together, these data demonstrate that changes in
HMGA1a levels cause an alteration of the expression of
architectural chromatin proteins and are therefore able
to modulate global chromatin composition on the level
of gene expression.
HMGA1a over-expression deregulates myogenic gene
expression
To examine whether the impaired myogenesis of C2A1a
cells could be due to altered expression of myogenic
factors we analyzed (by RT-PCR) the expression profiles
of the transcription factors myogenic factor 5 and 6
(Myf5 and Myf6), myocyte enhancer factor 2A (Mef2a),
the myogenic determination gene 1 (MyoD), myogenin
and the myogenic inhibitor homeobox, msh-like 1
(Msx1) (Fig. 6A). Compared to C2C12 cells, the expres-
sion of MyoD and myogenin was significantly suppressed
in C2A1a cells. Mef2a seemed to be only slightly down-
regulated. In contrast, the myogenic inhibitor Msx1 was
up-regulated. The expression profiles of other factors
involved in myogenic differentiation like Myf5 and Myf6
(Fig. 6A) remained unaffected by sustained HMGA1a
expression.
Besides transcription factors, growth factors such as
insulin-like growth factor 1 and 2 (Igf1 and Igf2)a r e
required for proper myogenesis. Igf binding proteins 1,
2, and 3 (Igfbp1, Igfbp2, Igfbp3) further fine tune the
bioavailability of Igf1 and Igf2. RT-PCR analyses
revealed that Igf1, Igf2, Igfbp2 and Igfbp3 were down-
regulated in C2A1a cells after induction, indicating that
HMGA1a that is present after induction is able to sup-
press the expression of components of the Igf-system
(Fig. 6B).
These data illustrate that a sustained high HMGA1a
protein level after induction of myogenesis alters the
expression of specific genes crucial for myogenesis and
prevents to establish a proper myogenic gene expression
profile.
Knock-down of HMGA1 in HMGA1a over-expressing cells
is sufficient to re-initiate myogenic differentiation
We performed siRNA experiments to examine whether
HMGA1 knock-down would restore the ability of
C2A1a cells to undergo myogenic differentiation.
Figure 6 Sustained HMGA1a-eGFP expression interferes with the expression of myogenic genes. (A) Comparison of expression profiles of
myogenic transcription factors in myoblasts (day 0) and during differentiation (days 1, 3, 6, 9 after induction). Gene expression was analyzed by
RT-PCR as described in Fig. 1. Genes analyzed were: myogenic factors 5 and 6 (Myf5 and Myf6), the myocyte enhancer factor 2A (Mef2a),
myogenic determination gene 1 (MyoD), myogenin and homeobox, msh-like 1 (Msx1). Note the specific down-regulation of MyoD and myogenin
and the up-regulation of the myogenic inhibitor Msx1 in C2A1a cells. As loading control Gapdh expression is shown. (B) Expression profiles of
components of the Igf-system in C2C12 and C2A1a cells at the time points described in (A). Genes analyzed were: insulin-like growth factors 1
and 2 (Igf1 and Igf2) and Igf binding proteins 1, 2 and 3 (Igfbp1, Igfbp2 and Igfbp3). Note the suppression of Igf1, Igf2, Igfbp2 and Igfbp3. Gapdh
expression is presented as a control.
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down through siRNA was not sufficient to initiate the
myogenic program and still required induction by
serum withdrawal (data not shown). However, siRNA
mediated knock-down of HMGA1a in C2A1a cells was
sufficient to reactivate the potential of C2A1a cells to
enter the myogenic program after induction. RT-PCR
revealed regained expression of MyoD, myogenin, myosin
lc and a-actin on day 3 after induction (Fig. 7A). these
data demonstrate that down-regulation of HMGA1a is a
crucial pre-requisite for the initiation of the myogenic
program after induction and necessary to enable C2C12
cells to establish a specific gene expression profile
that is essential for the correct course of myogenic
differentiation. Furthermore, knock-down of HMGA1a
in C2A1a cells restored myosin expression 3-6 days
after induction as well as chromocenter cluster-
ing accompanying terminal differentiation (Fig. 7B,
arrows and Fig. 7C). This supports that HMGA1a
down-regulation is crucial to activate the entire myo-
genic program including chromatin remodeling during
terminal differentiation.
Discussion
HMGA1 proteins are architectural chromatin proteins
known to be preferentially expressed in proliferating
embryonic tissues but absent in differentiated cells
[4,19]. HMGA1 proteins have been previously impli-
cated in the differentiation of several cell types. For
example HMGA1 affects lympho-hematopoietic differ-
entiation of mouse embryonic stem cells [20] and the
differentiation of sperm cells [21]. HMGA1 proteins
bind to adipocyte-specific promoters and down-regula-
tion has been shown to impair adipocytic differentiation
of 3T3-L1 cells [22]. Here we demonstrate that HMGA1
down-regulation is one of the first and essential steps to
allow myogenic differentiation of C2C12 cells. In con-
trast, sustained expression of HMGA1a-eGFP after
induction prevents myogenic differentiation. Mechanisti-
cally, the inhibition of C2C12 myogenesis is caused by a
specific down-regulation of the myogenic key transcrip-
tion factors MyoD and myogenin and several additional
factors that are required to progress myogenesis.
Several mechanisms have been described on how
HMGA proteins participate in specific gene expression,
for example the formation of enhanceosomes [8], bind-
ing to specific promoter regions to remove inhibitory
factors and to recruit chromatin remodeling complexes
or to interact with other transcription factors (e.g.
Smad1/4) [8,15,23,24].
The genes that are specifically targeted by HMGA1a
during C2C12 myogenesis remain to be examined. Cer-
tainly, the down-regulation of specific myogenic genes
through HMGA1a is indirect and may represent
Figure 7 Recovery of myogenic gene expression in C2A1a cells
after siRNA mediated HMGA1 depletion. (A) RT-PCR to analyze
myogenic gene expression after HMGA1 knock-down in C2A1a cells.
RT-PCR was as described in Fig. 1. Days of analyses are indicated.
Gapdh expression was used as a control. Note the recovery of
MyoD, myogenin, myosin lc and a-actin expression on day 3 of
differentiation after HMGA1 knock-down in C2A1a cells. (B)
Immunofluorescence localizations of myosin (red) in C2C12 and
C2A1a control cells (a, b) and C2C12 and C2A1a cells treated with
HMGA1 siRNA (a’,b ’) on day 6 after induction. DNA was stained
with Hoechst (blue). The siRNA treated C2C12 cells (a’) differentiate
as control treated C2C12 cells (a). Knock-down of HMGA1 in C2A1a
cells recovers myotube formation and myosin expression (b’). Note
that the number of chromocenters is reduced in these cells
indicating chromocenter clustering (arrows). Bar represents 100 μm.
(C) Chromocenter clustering occurs after HMGA1a knock-down in
C2A1a cells. Comparison of chromocenter numbers on day 6 of
differentiation in terminal differentiated C2C12 cells (grey columns),
C2A1a on day 6 throughout induction of myogenesis (green
columns) and myosin positive C2A1a cells after knock-down of
HMGA1a on day 6 of differentiation (red columns). The evaluation
of chromocenter numbers was as described in Fig. 4C.
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cades. For example, the decreased myogenin expression
is likely caused by the down-regulation of MyoD as well
as Mef2a. The latter was recently shown to be necessary
for efficient expression of myogenin through the binding
to its promoter [25]. MyoD in turn might be repressed
through up-regulation of its suppressor Msx1.E v e n
though elevated Msx1 expression in C2A1a cells was
just prominent until three days after induction, this
initial up-regulation might be sufficient to aggravate the
effects of inhibition on the myogenic program. In con-
trast, it is also conceivable that the differential expres-
sion of these genes observed in C2A1a cells is regulated
by HMGA1 independently of each other, while affecting
the differentiation program in a synergistic manner. Due
to this possibility, the promoters of MyoD, myogenin as
well as Msx1 are good potential candidates for being
direct HMGA1a targets. Other direct candidate genes
are those of the Igf-pathway which we found to be sup-
pressed through sustained HMGA1a expression (e.g.
Igf1, Igf2). Several previous reports discussed that Igf-
signaling is involved in sugar metabolism [26] and myo-
genic differentiation [27-29] and Igf1 depletion impairs
functional muscle development in mice [30-32]. Sup-
porting that, Igf1 induces myogenin expression followed
by cell cycle arrest and myogenic differentiation [33].
Depletion of Igf2 in C2 cells inhibits MyoD expression
and abolishes the ability of the cells to express myogenin
and myosin genes [34]. Thus, the observed deregulation
of the Igf-signaling through HMGA1a over-expression
may cause and/or amplify the lack of key myogenic
transcription factors and is in good correlation to our
observed inhibition of myogenesis.
Despite specific effects on gene promoters, sustained
HMGA1a expression may also affect gene regulation
through a more global regulation of chromatin architec-
ture. For example, it has been shown that HMGA1
binds to A/T-rich scaffold attachment regions (SARs)
which are thought to organize larger chromatin domains
[10]. Previous reports showed that HMGA proteins are
preferentially associated with heterochromatin [6,35].
This is supported by the preferential localization of
HMGA1a in chromocenters of C2C12 cells.
HMG proteins, histone H1 and many other chromatin
proteins are members of a large network of chromatin
binding factors that dynamically modulate chromatin
architecture through interaction and competition [3].
The function of this network also depends on the avail-
ability of HMGA1-interactors and competitors such as
histone H1 [3]. HMGA1 proteins were found to induce
transcription of previously suppressed plasmid templates
by displacement of histone H1 from SAR elements [36].
In support, it was shown that HMG proteins in general
compete for chromatin binding with histone H1 in
living cells [37]. The significantly decreased levels of his-
tone H1 in HMGA1a over-expressing C2C12 cells
demonstrate a shift in the regulatory equilibrium of
those two chromatin proteins, favoring HMGA1 binding
to previously H1-suppressed sites. This could lead to
the modulation of the structure and activity of large
chromatin loops and thus affect myogenic gene
expression.
The massive down-regulation of histone H1 was sur-
prising. This raises the question how the cells could tol-
erate this. However, besides histone H1 additional
chromatin proteins such as HMGB1, HMGN1 and
MeCP2 were also misregulated. This indicates that the
entire chromatin composition is altered and that the
loss of histone H1 may be compensated by other chro-
matin proteins like HMGB1 [38] or other differentiation
specific histone H1 variants which are not detected by
the H1 antibodies used. Within this context it is impor-
tant that the over-expression of HMGA1a-eGFP pre-
vented chromocenter remodeling and thus global
chromatin reorganization normally accompanying differ-
entiation. Interestingly, remodeling of chromocenters
was completely recovered after knock-down of
HMGA1a in C2A1a cells which was visual through
regained chromocenter clustering during the restored
terminal differentiation. Notably, the protein MeCP2,
which stabilizes chromocenter organization in differen-
tiated cells, was up-regulated in C2A1a cells. MeCP2
dynamically interplays with HP1 proteins, and it was
suggested that this interaction in turn stabilizes chroma-
tin organization [39]. Consistently, premature MeCP2
expression in HMGA1a over-expressing C2A1a cells
could therefore increase and stabilize the HP1 concen-
t r a t i o no nc h r o m a t i nw h i c hi nt u r nc o u l ds t a b i l i z ea
chromatin structure that prevents expression of genes
relevant for myogenic differentiation.
Conclusions
We have shown that down-regulation of HMGA1
chromatin proteins is crucial to initiate the myogenic
program after induction of C2C12 differentiation.
Thus, we provide an example how differential expres-
s i o no fH M G A 1p r o t e i n si si n v o l v e di nd i f f e r e n t i a t i o n
processes. After induction, sustained HMGA1a expres-
sion alters the transcription of genes that are relevant
for initiation and the proper course of myogenic differ-
entiation. Both, specific gene regulation and global
effects on chromatin may contribute to this deregu-
lated gene expression. Global effects involve deregu-
lated expression of other chromatin proteins such as
histone H1 and MeCP2, leading to a modified chroma-
tin composition. More generally, these latter data pro-
pose that altered levels of HMGA1 proteins are
connected to the expression of architectural chromatin
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matin composition.
This report contributes to the understanding of how
the differential expression of HMGA1 proteins is
involved in chromatin organiza t i o ni nu n d i f f e r e n t i a t e d
cells and during differentiation processes. Furthermore,
it may help to comprehend possible mechanisms of
HMGA function in malign and benign tumours that
over-express HMGA proteins.
Methods
Cell culture and differentiation
C2C12 cells were cultured in growth medium containing
DMEM 4.5 g/L glucose (Gibco/Invitrogen), supplemented
with 100 units/ml Penicillin, 100 μg/ml Streptomycin,
2 mM L-glutamine and 10% FCS. Myogenic differentiation
was induced with differentiation medium (DM) containing
DMEM 4.5 g/L glucose, 100 units/ml Penicillin, 100 μg/ml
Streptomycin, 2 mM L-glutamine and 2% horse serum
(Gibco/Invitrogen). Osteoblast differentiation was initiated
by addition of 0.5 μg/ml BMP2. C2C12 cells stably expres-
sing HMGA1a-eGFP constructs were generated by retro-
viral transduction as shown below. After isolation, cell
clones were grown and differentiated as described above.
293T cells were grown in DMEM 1 g/L glucose, sup-
plemented with 100 units/ml Penicillin, 100 μg/ml
Streptomycin and 10% FCS.
Cell transfections and production of ecotropic viruses for
transduction of C2C12 cells
To produce C2C12 cells stably expressing HMGA1a-
eGFP, cells were infected with ecotropic retroviruses. To
achieve this, 293T cells were transfected transiently with
pHIT60 [40] including gag-pol, pcziMEE bearing the
sequence of a mouse specific envelope protein (env) and
pLTR-HMGA1a-eGFP. The last two plasmids were
derived from pLTR-eGFP via deletion of the eGFP
sequence and insertion of HMGA1a-eGFP. 293T triple
transfection of retroviral vectors was performed with
MATra (IBA) using 6 μg of total plasmid DNA (2 μg
each plasmid). Medium was changed 24 h after transfec-
tion and 10 mM Na-butyrate (Sigma) was added. 8 h
after Na-butyrate treatment cells were washed and
grown for further 24 h in normal growth medium.
Supernatant was sterile filtered (45 μm) and mixed with
polyprene (Sigma) to a final concentration of 8 μg/ml.
The mixture was added to the C2C12 cells. After 8 h,
C2C12 cells were washed once in PBS and grown for
12 h in growth medium. Positive colonies were manually
selected using fluorescence microscopy.
Alkaline phosphatase staining
Cells grown on cover slips were fixed for 15 min in 2%
formaldehyde/PBS. After fixation the cells were washed
2 times in ALP buffer (100 mM Tris, pH 9.5; 100 mM
NaCl; 50 mM MgCl2) and incubated with 30 μlo fA L P
buffer containing 4.5 μl NBT (100 mg/ml in 70%
dimethylformamide; Roche) and 3.5 μlB C I P( 5 0m g / m l
in dimethylformamide; Roche) until AP staining was
visualized (~5-10 min). After two additional washing
steps, coverslips were mounted in Mowiol as described
[41].
FACS analysis
C2C12 and C2A1a cells were grown in a 60 mm culture
dish to ~80-90% confluence. Cells were removed from
the culture dish, washed in PBS for 10 min and pelleted
by centrifugation. The washing step was repeated twice
with a pre-warmed 2% FCS/PBS solution. Finally, cells
were resuspended in 1 ml 2% FCS/PBS. Then 3 ml ice
cold ethanol was added dropwise. Cells were fixed for 1
ha t4 ° C ,w a s h e dt w i c ei nP B Sa n dr e s u s p e n d e di n1m l
PBS. 50 μg of propidium iodide and 200 μgo fR N A s e
(Sigma) were added and incubated for 30 min at 37°C.
FACS analyses were carried out using a BD FACScan
cell sorter and CellQuest Pro Software.
siRNA treatment
RNA oligos (Biomers) used for siRNA experiments were
designed on basis of the genebank number AF285780:
mHMGA1a-Ex5-sense, 5’-aagucaccacagcuccaggga-3’;
mHMGA1a-Ex5-antisense 5’-ucccuggagcuguggugacuu-
3’; mA1a-Ex5-2-sense, 5’- aaggggcagacccaagaaacu-3’;
mA1a-Ex5-2 antisense, 5’-aguuucuugggucugccccuu-3’.
For siRNA controls the sequence of non-targeting
siRNA was used as described [42]. For annealing 30 μl
of sense and appropriate antisense oligo (50 μM each)
were mixed and 15 μl of 5x annealing buffer (50 mM
T r i s / H C l ,p H7 . 5 ;1 0 0m MN a C l )w a sa d d e d .T h ef i n a l
concentration of the duplex was 20 μM. Annealing was
performed in a PCR cycler at 95°C for 2 min and cool-
ing down to 20°C over 60 min. For siRNA transfection
2.5 μl( 5 0μM) of each siRNA duplex were mixed and
transfected into C2C12 cells using TransFectin (BioRad).
Knock-down of HMGA1a proteins was analyzed in
nuclei isolated 12-24 hours after siRNA transfection by
Western blot or by loss of HMGA1a-eGFP fluorescence.
Immunofluorescence procedures
C2C12 cell lines grown on coverslips were washed in
PBS for 5 min, fixed in 2% formaldehyde/PBS for 15
min, washed again and permeabilized for 15 min in
0.1% Triton X-100/PBS. After additional washing steps,
cells were incubated in 100 mM glycin/PBS. All anti-
body incubations were performed in a humidified
chamber. Following antibodies were used for immuno-
fluorescence: anti-MeCP2 (1:1000, abcam), anti-
H3K9me3 (1:1000, abcam), anti-H3K20me3 (1:500,
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Chemicon). Primary antibodies were incubated over
night at 4°C. After two washing steps in PBS, 25 μlo f
appropriate secondary antibodies were incubated
for 20 min. To stain DNA, 10 μlo fH o e c h s t / P B S
(5 μg / m l )w e r ea d d e da n di n c u b a t e df o rf u r t h e r1 0
min. After two final washing steps, coverslips were
mounted in Mowiol as described. Confocal analyses
were performed with a Leica TCS-SP2/AOBS using a
HCX Pl APO 63x 1.4 oil immersion objective, using
sequential scans and lasers with the appropriate
wavelengths.
RT-PCR, PCR and cloning
Total RNA was isolated using TriFast (Peqlab) according
to the manufacturer’s instruction. To produce cDNAs 1
μg of total RNA was reverse transcribed using oligo-dT18
primer and M-MLV reverse transcriptase (Promega). The
cDNAs were used as template to amplify coding sequences
or sequence parts of marker transcripts. The amplified
fragments were analyzed on 1% agarose gels. The cDNAs
coding for HMGA1a were produced by PCR using Phu-
sion polymerase (NEB). Primers and PCR conditions can
be delivered upon request to RH. All cDNAs were sub-
cloned and verified by sequencing.
Western blots
Cell nuclei were prepared as described [41]. 1.5 × 10
5
nuclei were loaded per lane and their proteins were
separated on a 15% SDS-polyacrylamide gel. Unstained
Protein Molecular Weight Marker (Fermentas) was used
as a protein size standard. SDS-PAGE and transfer onto
nitrocellulose was performed as described previously
[41]. Loading and transfer efficiency was controlled by
Ponceau S staining and appropriate Western blot con-
trols. Blocking was carried out with 5% non-fat dry milk
in TBST for 1 h. Nitrocellulose was washed three times
in TBST for 10 min and incubated with the first anti-
body over night at 4°C. After three washing steps in
TBST nitrocellulose membrane was incubated with the
appropriate peroxidase conjugated secondary antibody
in blocking solution. If necessary, nitrocellulose mem-
brane was blocked for a second time in 5% non-fat dry
milk/TBST prior to addition of the secondary antibody.
Detection was performed by enhanced chemilumines-
cence as described [41]. Following antibodies were used
for Western blot: anti-HMGA1 (1:2500, abcam), anti-
GFP (1:1000, Roche), anti-MeCP2 (1:2000, Upstate),
anti-HMGB1 (1:1000, Michael Bustin), anti-HMGN1
(1:1000, Micheal Bustin), anti-H1 (1:1000, Abcam), anti-
H1 (1:500, Michael Bustin [43]) which was elicited
against pure H1 subtractions and affinity purified against
a mixture of all H1 sub-variants and anti Lamin A/C
(1:5000, Santa Cruz).
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